Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration
- PMID: 16551485
- DOI: 10.1016/j.appet.2006.01.008
Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration
Abstract
Body weight gain is a worrying side effect of many new antipsychotic drugs. The mechanisms by which antipsychotic drugs increase weight in humans are not known. Attempts to model the metabolic effects of antipsychotic drugs in the animal have not been successful. Female rats appear to be sensitive to the effects of antipsychotics, but male rats less, and this does not match the clinical situation in humans. In previous rodent studies, antipsychotics were always given by daily gavage or injections. Antipsychotics have different pharmacokinetics in rodents and humans, and in the present study, we tested the hypothesis that the insensitivity of male rats to the effects of antipsychotics could be related to their mode of administration. Thus, we administered antipsychotic drugs mixed with the food. Animals were treated during 6 weeks with haloperidol (1mg/kg), olanzapine (1mg/kg), ziprasidone (10mg/kg), or a control solution. Animals were allowed to self-select food among three macronutrients (carbohydrates, lipids and proteins). Food selection was measured throughout the study. At the end of the study, body composition was measured by dissection and weighing of the rat's main organs and tissues. Mitochondrial thermogenesis was measured in brown adipose tissue in olanzapine-treated animals. Circulating leptin, insulin, glucose, triglycerides, cholesterol, high-density lipoprotein (HDL) were also assayed at the end of the study. The results show that none of the antipsychotic treatments modified caloric intake, food selection or body weight. Olanzapine did not alter mitochondrial thermogenesis. However, haloperidol and olanzapine induced a significant increase in adiposity and circulating leptin. Ziprasidone produced a moderate fat accumulation. It is concluded that mixing antipsychotic treatments with the food provides a reliable animal model of antipsychotic-induced fat accumulation.
Similar articles
-
Effects of chronic neuroleptic treatments on nutrient selection, body weight, and body composition in the male rat under dietary self-selection.Behav Brain Res. 2005 Sep 8;163(2):204-11. doi: 10.1016/j.bbr.2005.05.004. Behav Brain Res. 2005. PMID: 16009434
-
A model for antipsychotic-induced obesity in the male rat.Psychopharmacology (Berl). 2006 Sep;187(4):447-54. doi: 10.1007/s00213-006-0433-0. Epub 2006 Jun 17. Psychopharmacology (Berl). 2006. PMID: 16783538
-
Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression.Psychoneuroendocrinology. 2008 Jun;33(5):569-80. doi: 10.1016/j.psyneuen.2008.01.018. Epub 2008 Mar 20. Psychoneuroendocrinology. 2008. PMID: 18358632
-
Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.Pharmacol Res. 2016 Apr;106:51-63. doi: 10.1016/j.phrs.2016.02.011. Epub 2016 Feb 15. Pharmacol Res. 2016. PMID: 26892184 Review.
-
Olanzapine-induced weight gain: chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution.Eur J Pharmacol. 2008 May 6;585(1):130-6. doi: 10.1016/j.ejphar.2007.11.078. Epub 2008 Mar 4. Eur J Pharmacol. 2008. PMID: 18378227 Review.
Cited by
-
Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes.Front Neurosci. 2017 Nov 21;11:643. doi: 10.3389/fnins.2017.00643. eCollection 2017. Front Neurosci. 2017. PMID: 29209160 Free PMC article. Review.
-
Atypical antipsychotics and effects on feeding: from mice to men.Psychopharmacology (Berl). 2016 Jul;233(14):2629-53. doi: 10.1007/s00213-016-4324-8. Epub 2016 Jun 1. Psychopharmacology (Berl). 2016. PMID: 27251130 Review.
-
The Novel Perspectives of Adipokines on Brain Health.Int J Mol Sci. 2019 Nov 11;20(22):5638. doi: 10.3390/ijms20225638. Int J Mol Sci. 2019. PMID: 31718027 Free PMC article. Review.
-
Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain.PLoS One. 2012;7(3):e33548. doi: 10.1371/journal.pone.0033548. Epub 2012 Mar 16. PLoS One. 2012. PMID: 22438946 Free PMC article.
-
Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors.Psychopharmacology (Berl). 2009 Nov;207(1):119-25. doi: 10.1007/s00213-009-1639-8. Epub 2009 Aug 18. Psychopharmacology (Berl). 2009. PMID: 19688201
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources